Oncotarget, a leading peer-reviewed medical journal, published the first scientific study of the University of Rochester (UR) Medical Center. The study suggested that e-cigarettes were similar to conventional cigarettes because they both damaged the gums and teeth of smokers. A Ph.D. Professor of Environmental Medicine at the prestigious University of Rochester School of Medicine and Dentistry, Irfan Rahman, led the study, which addressed the harmful effects of e-cigarettes on the oral health of smokers on molecular and cellular levels.
E-cigarettes are continuously being used by youths, former, and current smokers who believe that it is a healthier alternative compared to the conventional cigarettes. The growing scientific research is opposing the previous studies by scientists who thought that the reason for the adverse health effects was because of the chemical found in cigarette smoke. Check Oncotarget at scimagojr.com
The Study Report
Rahman, alongside the team of researchers for the study, cited that cigarette released vapors when burned, making cells to release inflammatory protein. These proteins exacerbate stress within cells, which ultimately cause various oral diseases. He added that the time and amount of cigarettes an individual consumes, would determine his/her exposure to gums and oral cavity.
The study showed that non-smokers were affected by the flavoring chemicals of cigarettes. A post-doctoral student from Eastman Institute of Oral Health, Fawad Javed, mentioned that they learned that cigarette flavorings caused more damage to the cell in the mouth. Fawad added that e-cigarettes contained nicotine, which contributes to gum disease.
Most e-cigarettes have a heating device, battery, and a cartridge for holding liquid, which contains flavorings, nicotine, and other chemicals. Further, the battery heats the liquid to produce an aerosol, which is being consumed by the user. Rahman cited that more research was needed to determine and recognize the health effects of e-cigarettes.
Oncotarget is a globally-known peer-reviewed medical journal that focuses on the pathological basis of cancer, and potential targets for therapy sessions. This journal also focuses on treatment protocols adopted to manage cancer patients. Oncotarget explores the evidence behind existing and new therapies to improve outcomes as well as seeking to define their applicability regarding uptake and acceptance by the patient. Visit Oncotarget’s profile page at Facebook.